Alejandro González Veliz/LinkedIn
Jun 23, 2026, 09:36
Alejandro González Veliz: Key Takeaways from the 2026 ACC/AHA Dyslipidemia Guidelines
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn:
“Dyslipidemia management is entering a new era.
The 2026 ACC/AHA Guideline moves beyond LDL-C alone and embraces a more personalized approach to cardiovascular prevention.
- LDL-C goals are back
- Lp(a) should be measured at least once
- ApoB helps uncover residual risk
- Coronary calcium refines risk assessment
- Earlier intervention may change lifelong outcomes
The message is simple: identify risk earlier, treat smarter, and prevent ASCVD before the first event occurs.
Which update do you think will have the greatest impact on your daily practice?
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 23, 2026, 07:45Cerebral Venous Sinus Thrombosis: New Diagnostic Approaches
-
Jun 23, 2026, 07:07Jungmok Seo: A Quinone-Activated Hydrogel for Second-Scale Hemostasis and Suture-Free Surgical Sealing
-
Jun 23, 2026, 06:25Melissa Hollo: The Hidden Burden of Anemia in Cardiovascular Disease
-
Jun 23, 2026, 06:04William Wallace: Why Normal Bloodwork Doesn’t Always Mean Normal Iron Stores
-
Jun 23, 2026, 05:33Rob Maloney: Why Coordination Matters More Than Capacity
-
Jun 22, 2026, 21:06Marios Bantidos: Can a Routinely Available Metabolic Index Improve Prediction of Angiographic Outcomes in STEMI?
-
Jun 22, 2026, 20:53Kirti Gupta: What is a DVT Scan?
-
Jun 22, 2026, 20:47Ifeanyichukwu Ifechidere: Advancing Education, Research, and Laboratory Excellence in APS
-
Jun 22, 2026, 20:46Mohamed Abdel Moneim: Proud to Contribute to 2 Publications on Obesity and VTE Risk